Standardizing Biomarker Testing for Canadian Patients with Advanced Lung Cancer
Abstract
Share and Cite
Melosky, B.; Blais, N.; Cheema, P.; Couture, C.; Juergens, R.; Kamel-Reid, S.; Tsao, M.-S.; Wheatley-Price, P.; Xu, Z.; Ionescu, D.N. Standardizing Biomarker Testing for Canadian Patients with Advanced Lung Cancer. Curr. Oncol. 2018, 25, 73-82. https://doi.org/10.3747/co.25.3867
Melosky B, Blais N, Cheema P, Couture C, Juergens R, Kamel-Reid S, Tsao M-S, Wheatley-Price P, Xu Z, Ionescu DN. Standardizing Biomarker Testing for Canadian Patients with Advanced Lung Cancer. Current Oncology. 2018; 25(1):73-82. https://doi.org/10.3747/co.25.3867
Chicago/Turabian StyleMelosky, B., N. Blais, P. Cheema, C. Couture, R. Juergens, S. Kamel-Reid, M.-S. Tsao, P. Wheatley-Price, Z. Xu, and D.N. Ionescu. 2018. "Standardizing Biomarker Testing for Canadian Patients with Advanced Lung Cancer" Current Oncology 25, no. 1: 73-82. https://doi.org/10.3747/co.25.3867
APA StyleMelosky, B., Blais, N., Cheema, P., Couture, C., Juergens, R., Kamel-Reid, S., Tsao, M. -S., Wheatley-Price, P., Xu, Z., & Ionescu, D. N. (2018). Standardizing Biomarker Testing for Canadian Patients with Advanced Lung Cancer. Current Oncology, 25(1), 73-82. https://doi.org/10.3747/co.25.3867